1. Home
  2. TNGX vs PBFS Comparison

TNGX vs PBFS Comparison

Compare TNGX & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • PBFS
  • Stock Information
  • Founded
  • TNGX 2014
  • PBFS 1889
  • Country
  • TNGX United States
  • PBFS United States
  • Employees
  • TNGX N/A
  • PBFS N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • PBFS Banks
  • Sector
  • TNGX Health Care
  • PBFS Finance
  • Exchange
  • TNGX Nasdaq
  • PBFS Nasdaq
  • Market Cap
  • TNGX 351.2M
  • PBFS 287.0M
  • IPO Year
  • TNGX N/A
  • PBFS N/A
  • Fundamental
  • Price
  • TNGX $6.01
  • PBFS $12.31
  • Analyst Decision
  • TNGX Strong Buy
  • PBFS
  • Analyst Count
  • TNGX 6
  • PBFS 0
  • Target Price
  • TNGX $12.20
  • PBFS N/A
  • AVG Volume (30 Days)
  • TNGX 2.7M
  • PBFS 35.7K
  • Earning Date
  • TNGX 08-06-2025
  • PBFS 05-09-2025
  • Dividend Yield
  • TNGX N/A
  • PBFS N/A
  • EPS Growth
  • TNGX N/A
  • PBFS 27.31
  • EPS
  • TNGX N/A
  • PBFS 0.80
  • Revenue
  • TNGX $40,990,000.00
  • PBFS $88,641,000.00
  • Revenue This Year
  • TNGX N/A
  • PBFS N/A
  • Revenue Next Year
  • TNGX N/A
  • PBFS N/A
  • P/E Ratio
  • TNGX N/A
  • PBFS $15.62
  • Revenue Growth
  • TNGX 10.09
  • PBFS 21.19
  • 52 Week Low
  • TNGX $1.03
  • PBFS $10.07
  • 52 Week High
  • TNGX $12.02
  • PBFS $12.65
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 76.36
  • PBFS 65.28
  • Support Level
  • TNGX $5.34
  • PBFS $11.91
  • Resistance Level
  • TNGX $6.40
  • PBFS $12.65
  • Average True Range (ATR)
  • TNGX 0.50
  • PBFS 0.40
  • MACD
  • TNGX -0.02
  • PBFS 0.06
  • Stochastic Oscillator
  • TNGX 84.08
  • PBFS 92.80

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

Share on Social Networks: